Incidence
In this study, we identified 1106 cases as DAMAR from 102430 cases of
inpatients, with the incidence of 1.08%. 125 of them with above 1000
IU/L CK values were identified as rhabdomyolysis with the incidence of
0.12%. The incidence of severe adverse reaction resembled with previous
study reported 0.11% [14], but which only
collected data with CK increased in 12 weeks in total, lacking large
sample proof.